Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Interest & Investment Income (2021 - 2025)

Amylyx Pharmaceuticals has reported Interest & Investment Income over the past 5 years, most recently at $3.3 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at $3.3 million for Q4 2025, up 42.06% from a year ago — trailing twelve months through Dec 2025 was $9.3 million (down 32.64% YoY), and the annual figure for FY2025 was $9.3 million, down 32.64%.
  • Interest & Investment Income for Q4 2025 was $3.3 million at Amylyx Pharmaceuticals, up from $1.8 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for AMLX hit a ceiling of $4.4 million in Q4 2023 and a floor of $1000.0 in Q2 2021.
  • Median Interest & Investment Income over the past 5 years was $2.3 million (2024), compared with a mean of $2.2 million.
  • Biggest five-year swings in Interest & Investment Income: soared 40100.0% in 2022 and later plummeted 51.83% in 2025.
  • Amylyx Pharmaceuticals' Interest & Investment Income stood at $30000.0 in 2021, then surged by 10423.33% to $3.2 million in 2022, then skyrocketed by 38.45% to $4.4 million in 2023, then plummeted by 47.01% to $2.3 million in 2024, then surged by 42.06% to $3.3 million in 2025.
  • The last three reported values for Interest & Investment Income were $3.3 million (Q4 2025), $1.8 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.